SensoDetect AB announces that CEO PA Hedin and Dr. Mohamed Hussein Atwa, Global Head of Clinical Research, will present at Redeye Theme: Medtech & Diagnostics on Wednesday this week.

Presentation date and time: 2025-11-12 at 09:25

Format: 12 min presentation + 8 min Q&A

Language: English
 

Event page and livestream

https://www.redeye.se/events/1110236/redeye-theme-medtech-diagnostics-4

This is the 12th annual Redeye event focusing on the Medtech & Diagnostics sector. The program begins with a market introduction by Redeye's analysts, followed by presentations from selected companies at varying stages of development. A number of investors will attend onsite, and the event will also be streamed live. Viewers may submit questions directly through the event page, with Q&A moderated by Redeye's analyst team.
 

PA Hedin, CEO SensoDetect AB, comments

"SensoDetect is now advancing toward scaled deployment. We continue to build momentum through clinical data, international partnerships, and concrete implementation pathways. We will trough our presentation "We Measure What Others Cannot - Scaling the Global Standard in Neuro-Auditory Brain Screening show the market on our progress and new strategic direction."
 

Dr. Mohamed Hussein Atwa, Global Head of Clinical Research, adds

"Our clinical work continues to demonstrate strong consistency and applicability across regions. The interest we are receiving from private schools and public health stakeholders reflects both medical need and the practicality of our approach."
 

A recording of the presentation will be made available through Redeye's platform after the event.